Miniatura

Fitxers

720144.pdf (422.13 KB)

Tipus de document

Article

Versió

Versió acceptada

Data de publicació

2021

Llicència de publicació

cc-by-nc-nd (c) Elsevier, 2021
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/184087

Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1016/j.jhep.2021.09.008

Resum

Background & aims: Autophagy-related gene 3 (ATG3) is an enzyme mainly known for its actions in the LC3 lipidation process, which is essential for autophagy. Whether ATG3 plays a role in lipid metabolism or contributes to non-alcoholic fatty liver disease (NAFLD) remains unknown. Methods: By performing proteomic analysis on livers from mice with genetic manipulation of hepatic p63, a regulator of fatty acid metabolism, we identified ATG3 as a new target downstream of p63. ATG3 was evaluated in liver samples from patients with NAFLD. Further, genetic manipulation of ATG3 was performed in human hepatocyte cell lines, primary hepatocytes and in the livers of mice. Results: ATG3 expression is induced in the liver of animal models and patients with NAFLD (both steatosis and non-alcoholic steatohepatitis) compared with those without liver disease. Moreover, genetic knockdown of ATG3 in mice and human hepatocytes ameliorates p63- and diet-induced steatosis, while its overexpression increases the lipid load in hepatocytes. The inhibition of hepatic ATG3 improves fatty acid metabolism by reducing c-Jun N-terminal protein kinase 1 (JNK1), which increases sirtuin 1 (SIRT1), carnitine palmitoyltransferase 1a (CPT1a), and mitochondrial function. Hepatic knockdown of SIRT1 and CPT1a blunts the effects of ATG3 on mitochondrial activity. Unexpectedly, these effects are independent of an autophagic action. Conclusions: Collectively, these findings indicate that ATG3 is a novel protein implicated in the development of steatosis. Lay summary: We show that autophagy-related gene 3 (ATG3) contributes to the progression of non-alcoholic fatty liver disease in humans and mice. Hepatic knockdown of ATG3 ameliorates the development of NAFLD by stimulating mitochondrial function. Thus, ATG3 is an important factor implicated in steatosis. Keywords: ATG3; NAFLD; NASH; lipid metabolism; mitochondria; sirtuin 1.

Matèries

Metabolisme dels lípids, Mitocondris

Matèries (anglès)

Lipid metabolism, Mitochondria

Citació

Col·leccions

Articles publicats en revistes (Bioquímica i Fisiologia)

Citació

DA SILVA LIMA, Natália, FONDEVILA, Marcos f., NOVOA PARDO, Eva maria, BUQUÉ, Xabier, MERCADO-GÓMEZ, Maria, GALLET, Sarah, GONZÁLEZ-RELLAN, Maria j., FERNANDEZ, Uxia, LOYENS, Anne, GARCÍA-VENCE, Maria, CHANTADA-VÁZQUEZ, Maria del pilar, BRAVO, Susana, MARAÑON, Patricia, SENRA, Ana, ESCUDERO, Adriana, LEIVA, Magdalena, GUALLAR, Diana, FIDALGO, Miguel, GOMES, Pedro, CLARET I CARLES, Marc, SABIO, Guadalupe, VARELA REY, Marta, DELGADO, Teresa c., MONTERO-VALLEJO, Rocio, AMPUERO, Javier, LÓPEZ, Miguel, DIÉGUEZ, Carlos, HERRERO RODRÍGUEZ, Laura, SERRA I CUCURULL, Dolors, SCHWANINGER, Markus, PREVOT, Vincent, GALLEGO DURÁN, Rocío, ROMERO GÓMEZ, Manuel 1967-, IRUZUBIETA, Paula, CRESPO, Javier, MARTÍNEZ CHANTAR, Maria luz, GARCÍA MONZÓN, Carmelo, GONZÁLEZ RODRÍGUEZ, Águeda, ASPICHUETA, Patricia, NOGUEIRAS, Rubén. Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function. _Journal of Hepatology_. 2021. Vol. 76, núm. 11-14. [consulta: 23 de gener de 2026]. ISSN: 0168-8278. [Disponible a: https://hdl.handle.net/2445/184087]

Exportar metadades

JSON - METS

Compartir registre